- Home
- INO vs OPRX Comparison
INO vs OPRX Comparison
Compare INO & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INO | OPRX |
|---|---|---|
| Founded | 1979 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.0M | 115.4M |
| IPO Year | 1999 | 2008 |
Fundamental Metrics
Financial Performance| Metric | INO | OPRX |
|---|---|---|
| Price | $1.64 | $6.40 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $6.75 | ★ $16.67 |
| AVG Volume (30 Days) | ★ 695.8K | 541.8K |
| Earning Date | 03-12-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 54.18 | ★ 124.55 |
| EPS | N/A | ★ 0.27 |
| Revenue | $42,220,086.00 | ★ $109,429,000.00 |
| Revenue This Year | $24,407.60 | $3.88 |
| Revenue Next Year | $331.40 | $8.49 |
| P/E Ratio | ★ N/A | $24.44 |
| Revenue Growth | ★ 19.37 | 18.78 |
| 52 Week Low | $1.30 | $5.54 |
| 52 Week High | $2.86 | $22.25 |
Technical Indicators
Market Signals| Indicator | INO | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 49.08 | 39.62 |
| Support Level | $1.48 | $5.74 |
| Resistance Level | $1.78 | $14.11 |
| Average True Range (ATR) | 0.09 | 0.45 |
| MACD | -0.01 | 0.17 |
| Stochastic Oscillator | 53.70 | 29.26 |
Price Performance
Historical ComparisonAbout INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.